L & S Advisors Inc Sells 345 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

L & S Advisors Inc decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.2% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 7,931 shares of the medical equipment provider’s stock after selling 345 shares during the period. L & S Advisors Inc’s holdings in Intuitive Surgical were worth $4,160,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Manchester Financial Inc. acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $25,000. Icon Wealth Partners LLC acquired a new position in shares of Intuitive Surgical during the 1st quarter worth approximately $26,000. Advisory Alpha LLC acquired a new position in shares of Intuitive Surgical during the 1st quarter worth approximately $32,000. Glassman Wealth Services increased its holdings in shares of Intuitive Surgical by 207.7% during the 1st quarter. Glassman Wealth Services now owns 80 shares of the medical equipment provider’s stock worth $46,000 after acquiring an additional 54 shares during the last quarter. Finally, FNY Investment Advisers LLC acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $47,000. Hedge funds and other institutional investors own 85.97% of the company’s stock.

A number of research analysts recently weighed in on the company. BidaskClub lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Wednesday. Canaccord Genuity reissued a “buy” rating and set a $610.00 target price (up from $575.00) on shares of Intuitive Surgical in a report on Friday, July 19th. Piper Jaffray Companies boosted their target price on Intuitive Surgical from $610.00 to $633.00 and gave the stock an “overweight” rating in a report on Friday, July 19th. Morgan Stanley set a $620.00 target price on Intuitive Surgical and gave the stock a “buy” rating in a report on Friday, July 19th. Finally, Cantor Fitzgerald set a $620.00 price objective on Intuitive Surgical and gave the company a “buy” rating in a report on Friday, July 19th. Three analysts have rated the stock with a sell rating, four have issued a hold rating and eight have given a buy rating to the company. Intuitive Surgical has a consensus rating of “Hold” and an average price target of $575.33.

In other news, COO Salvatore Brogna sold 1,171 shares of the stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $505.23, for a total transaction of $591,624.33. Following the sale, the chief operating officer now directly owns 5,933 shares of the company’s stock, valued at approximately $2,997,529.59. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Reiter Kara Andersen sold 4,120 shares of the stock in a transaction on Wednesday, July 24th. The stock was sold at an average price of $540.00, for a total value of $2,224,800.00. Following the sale, the senior vice president now directly owns 7,838 shares in the company, valued at $4,232,520. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 25,869 shares of company stock worth $13,664,252. Insiders own 1.70% of the company’s stock.

Shares of NASDAQ ISRG opened at $524.64 on Friday. The stock’s fifty day moving average price is $508.23 and its two-hundred day moving average price is $522.18. Intuitive Surgical, Inc. has a one year low of $430.24 and a one year high of $589.32. The firm has a market cap of $60.46 billion, a price-to-earnings ratio of 55.28, a P/E/G ratio of 3.89 and a beta of 1.13.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $3.25 EPS for the quarter, beating analysts’ consensus estimates of $2.23 by $1.02. Intuitive Surgical had a return on equity of 17.35% and a net margin of 29.95%. The firm had revenue of $1.10 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same period in the prior year, the firm posted $2.76 EPS. The company’s revenue for the quarter was up 20.9% on a year-over-year basis. As a group, research analysts expect that Intuitive Surgical, Inc. will post 10.12 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Further Reading: What does the Producer Price Index (PPI) tell investors?

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.